Literature DB >> 15253929

Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.

Marina Cesaretti1, Elisa Luppi, Francesca Maccari, Nicola Volpi.   

Abstract

Heparin with high anticoagulant activity (activated partial thromboplastin time of 347 +/- 56.4 and anti-Xa activity of 317 +/- 48.3) was isolated from the marine clam species Tapes phylippinarum in an amount of approximately 2.1 mg/g dry animals. Agarose-gel electrophoresis showed a high content of the slow-moving heparin component (22 +/- 6.8%) and 78 +/- 5.4% of the fast-moving species. An average molecular mass of 13,600 was calculated by PAGE analysis, whereas a number average molecular weight Mn value of 10,700, a weight average molecular weight Mw of 14,900, and a dispersity index Mn/Mw of 1.386 were obtained by high-performance size-exclusion chromatography. Structural analysis of clam heparin, performed by depolymerizing heparin samples with heparinase (EC 4.2.2.7) and then separating the resulting unsaturated oligosaccharides by strong anion exchange-HPLC revealed the presence of large amounts (more than 130% than standard pharmaceutical heparin obtained from bovine intestine) of the oligosaccharide sequence bearing part of the ATIII-binding region, DeltaUA2S (1-->4)-alpha-D-GlcN2S6S (1-->4)-alpha-L-IdoA (1-->4)-alpha-D-GlcNAc6S (1-->4)-beta-D-GlcA (1-->4)-alpha-D-GlcN2S3S6S in the T. phylippinarum heparin, in comparison with bovine mucosal heparin and a sample of porcine mucosal heparin previously published. Furthermore, as expected from the oligosaccharide compositional analysis, due to the presence of a great mol % (80.6%) of the trisulfated disaccharide DeltaUA2S(1-->4)-alpha-D-GlcN2S6S, mollusc heparin is a more sulfated polysaccharide than bovine mucosal heparin (73.5%) and a sample of porcine mucosal (72.8%) heparin previously reported. To our knowledge, this is the first article describing a clam heparin having the ATIII binding site mainly identical to that of human and porcine intestinal mucosal heparins and bovine intestinal mucosal heparin but different from that found in beef lung heparin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15253929     DOI: 10.1093/glycob/cwh128

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  12 in total

1.  Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.

Authors:  Mohammad Warda; Robert J Linhardt
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2005-11-17       Impact factor: 2.231

2.  Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.

Authors:  Zhenyu Wang; Bo Yang; Zhenqing Zhang; Mellisa Ly; Majde Takieddin; Shaker Mousa; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2011-04-12       Impact factor: 4.813

3.  Evolution of glycosaminoglycans: Comparative biochemical study.

Authors:  Shuhei Yamada; Kazuyuki Sugahara; Suat Ozbek
Journal:  Commun Integr Biol       Date:  2011-03

4.  Distribution analysis of polysaccharides comprised of uronic acid-hexose/hexosamine repeating units in various shellfish species.

Authors:  Chunyang Cao; Shuang Song; Bin Liu; Chunqing Ai; Zhenjun Zhu; Lilong Wang; Sufeng Wu
Journal:  Glycoconj J       Date:  2018-10-15       Impact factor: 2.916

5.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

6.  Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.

Authors:  Angélica M Gomes; Eliene O Kozlowski; Vitor H Pomin; Cintia Monteiro de Barros; José L Zaganeli; Mauro S G Pavão
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

7.  Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.

Authors:  Joana C Santos; Juliana M F Mesquita; Celso L R Belmiro; Carolina B M da Silveira; Christian Viskov; Pierre A Mourier; Mauro S G Pavão
Journal:  Thromb Res       Date:  2007-05-04       Impact factor: 3.944

8.  Mosquito heparan sulfate and its potential role in malaria infection and transmission.

Authors:  Photini Sinnis; Alida Coppi; Toshihiko Toida; Hidenao Toyoda; Akiko Kinoshita-Toyoda; Jin Xie; Melissa M Kemp; Robert J Linhardt
Journal:  J Biol Chem       Date:  2007-06-27       Impact factor: 5.157

Review 9.  Mast cell glycosaminoglycans.

Authors:  B Mulloy; R Lever; C P Page
Journal:  Glycoconj J       Date:  2016-11-30       Impact factor: 2.916

10.  Anti-Inflammatory Effects of a Mytilus coruscus α-d-Glucan (MP-A) in Activated Macrophage Cells via TLR4/NF-κB/MAPK Pathway Inhibition.

Authors:  Fuyan Liu; Xiaofeng Zhang; Yuqiu Li; Qixin Chen; Fei Liu; Xiqiang Zhu; Li Mei; Xinlei Song; Xia Liu; Zhigang Song; Jinhua Zhang; Wen Zhang; Peixue Ling; Fengshan Wang
Journal:  Mar Drugs       Date:  2017-09-20       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.